University of Cincinnati

Plus: Changes at Halda, Calidi, Creyon, Aurion, Protalix, Theradaptive and Boston Scientific

BioCentury’s roundup of translational innovations also includes a study from Amgen and a newco spotlight

BioCentury’s roundup of translational innovations

Vancouver-based Reverb is making bispecific antibodies to nab cytokines and deliver them to a desired cell or tissue

Plus Protano named CFO at Alltrna, and updates from Laronde, Xentria and more

‘Exceptional litigator’ was an agency alum, handled cases before WHO, U.N.

mRNA company CureVac N.V. (NASDAQ:CVAC) hired Malte Greune as COO. He joins from Sanofi-Aventis Deutschland GmbH, where he served for nine years, most recently as general manager and VP of the

DISEASE CATEGORY: Autoimmune disease
INDICATION: Lupus Lipid nanoparticle-based T-cell specific inhibition of the potassium channel KCNA3 could treat lupus nephritis. The nanoparticles contain an

Cincinnati team makes multi-organ systems in lab for disease modeling, regenerative med